Mode
Text Size
Log in / Sign up
N/A Completed N=73 Randomized Double-blind Prevention

Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study

Source: ClinicalTrials.gov NCT00756886 ↗
Enrolled (actual)
73
Serious AEs
25.5%
Results posted
Apr 2013
Primary outcomePrimary: Atrial Fibrillation — 6; 1 participants

Summary

The purpose of this study is to determine if atorvastatin (Lipitor) reduces the occurence of abnormal heart rhythm (atrial arrhythmia) following non cardiac thoracic surgery.

Outcome Measures

OutcomeResultp-value
PRIMARY
Atrial Fibrillation
6; 1

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled for elective non-cardiac thoracic surgery requiring thoracotomy for resection

Exclusion Criteria

  • Past medical history of pacemaker implantation
  • Pregnancy or lactating
  • History of Atrial arrhythmia within the past year
  • Elevated liver enzymes pre-operatively
  • Past medical history of any liver disease or history of liver transplantation
  • Use of statins or any anti-arrhythmics (including beta-blockers, calcium channel blockers, digoxin) within 3 months prior to surgery
  • Pre-op EKG showing atrial arrhythmia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00756886). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search